Peking Medicine Manufactory FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Peking Medicine Manufactory has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 2 compliance actions on record. FDA has issued 2 warning letters to Peking Medicine Manufactory, the most recent on Mar 25, 2013.

What these totals cover: FDA records filed under the name "Peking Medicine Manufactory".

Latest inspection
Apr 30, 2012 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections1Nov 14, 2026Newest record Nov 5, 2026Current
Compliance actions2Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Peking Medicine Manufactory as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Peking Medicine Manufactory yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Peking Medicine Manufactory FDA Warning Letters

2 warning letters from Apr 5, 2012 to Mar 25, 2013.

IssuedSubjectIssuing officeClose-out letter
Mar 25, 2013 · Record page
Apr 5, 2012 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

1 inspection on Apr 30, 2012.

DateSiteProductClassificationFEI
Apr 30, 2012Tsuen Wan, Hong Kong SARDrugsOfficial Action Indicated (OAI)3004186759
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 2 compliance actions under Peking Medicine Manufactory: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Mar 25, 2013.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3004186759Tsuen Wan, Hong Kong SAR1Apr 30, 2012

Peking Medicine Manufactory and the FDA: common questions

Has Peking Medicine Manufactory received an FDA warning letter?

Yes. FDA has issued 2 warning letters to Peking Medicine Manufactory. The most recent is dated Mar 25, 2013.

Has Peking Medicine Manufactory received an FDA Form 483?

FDA has not published a Form 483 for "Peking Medicine Manufactory" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Peking Medicine Manufactory?

The most recent FDA inspection on file ended Apr 30, 2012 at Tsuen Wan, Hong Kong SAR and was classified OAI. FDA has 1 inspection of Peking Medicine Manufactory on file, 1 of them classified OAI (official action indicated).

Need more than this page shows? Ask about Peking Medicine Manufactory in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.